Bone Marrow

• 

  Subject Areas on Research

  • 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. 
  • 9p- in a girl with acute lymphocytic leukemia and sickle cell disease. 
  • A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial. 
  • A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse. 
  • A cellular protein is immunologically crossreactive with and functionally homologous to the Fujinami sarcoma virus transforming protein. 
  • A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy. 
  • A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells. 
  • A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. 
  • A mouse model of adult-onset anaemia due to erythropoietin deficiency. 
  • A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. 
  • A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer. 
  • A quantitative histologic study of avian osteopetrotic bone demonstrating normal osteoclast numbers and increased osteoblastic activity. 
  • A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group. 
  • A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. 
  • A spectrum of severe familial liver disorders associate with telomerase mutations. 
  • AAOS Technology Overview Summary: Concentrated Bone Marrow Aspirate for Knee Osteoarthritis. 
  • Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. 
  • Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. 
  • Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer. 
  • Acute graft-vs-host disease: pathobiology and management. 
  • Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapy. 
  • Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. 
  • Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study. 
  • Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. 
  • Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma. 
  • Altered immune responses in apolipoprotein E-deficient mice. 
  • An analysis of the presence of Fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia. A Pediatric Oncology Group study. 
  • An auxotrophic pigmented Cryptococcus neoformans strain causing infection of the bone marrow. 
  • An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis. 
  • Analysis of erythropoietin and erythropoietin receptor genes expression in cattle during acute infection with Trypanosoma congolense. 
  • Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. 
  • Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. 
  • Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells. 
  • Aplastic anemia in a patient with Rothmund-Thomson syndrome. 
  • Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia. 
  • Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis. 
  • Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. 
  • Beyond angiogenesis: the role of endothelium in the bone marrow vascular niche. 
  • Bone Marrow Aspirate Concentrate for Bone Healing in Foot and Ankle Surgery. 
  • Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success. 
  • Bone marrow enhancement during time-resolved magnetic resonance angiography of the pelvis. 
  • Bone marrow morphologic and neuroradiologic findings in a case of pediatric myelodysplastic syndrome arising in ataxia-pancytopenia syndrome. 
  • Both Hematopoietic- and Non-hematopoietic-derived {beta}-arrestin-2 Regulates Murine Allergic Airway Disease. 
  • CCR5 Signaling Promotes Murine and Human Hematopoietic Regeneration following Ionizing Radiation. 
  • CNS inflammation and bone marrow neuropathy in type 1 diabetes. 
  • Cancer chemotherapy in older adults. A tolerability perspective. 
  • Candidate genes on murine chromosome 8 are associated with susceptibility to Staphylococcus aureus infection in mice and are involved with Staphylococcus aureus septicemia in humans. 
  • Carcinogenicity of inhaled benzene in CBA mice. 
  • Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C. 
  • Causes of death on antiretroviral therapy: a post-mortem study from South Africa. 
  • Central nervous system leukaemia. 
  • Changes in bone marrow pressure in response to hyperbaric exposure. 
  • Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1. 
  • Characterization of cytotoxic cells generated from in vitro cultures of murine bone marrow cells. 
  • Characterization of human CD7 transgenic mice. 
  • Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas. 
  • Chemotherapy and the bone marrow stroma. 
  • Chemotherapy dose intensity and quality cancer care. 
  • Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays. 
  • Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. 
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic axial compression of the mouse tail segment induces MRI bone marrow edema changes that correlate with increased marrow vasculature and cellularity. 
  • Cisplatin, BCNU, cyclophosphamide, and prednisone in multiple myeloma. 
  • Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. 
  • Clinical characteristics of testicular extramedullary involvement in multiple myeloma. 
  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. 
  • Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: a Pediatric Oncology Group study. 
  • Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. 
  • Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia. 
  • Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. 
  • Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas. 
  • Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. 
  • Comparison of the effects of IL-1 alpha and TNF-alpha on phagocyte accumulation and murine antibacterial immunity. 
  • Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells. 
  • Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia. 
  • Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. 
  • Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy. 
  • Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases. 
  • Congenital bone marrow failure with myelodysplasia in siblings. 
  • Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR). 
  • Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics. 
  • Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cells. 
  • Continuous-infusion diaziquone in acute myeloid leukemia: a Southeastern Cancer Study Group trial. 
  • Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. 
  • Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. 
  • Cost effectiveness of myeloid growth factors in cancer chemotherapy. 
  • Costs associated with febrile neutropenia in the US. 
  • Customization of the TRU-PBMT App (Technology Recordings to better Understand Pediatric Blood and Marrow Transplant). 
  • Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. 
  • Debridement, Curettage, and Bone Marrow Stimulation: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle. 
  • Dendriform pulmonary ossification. Report of two cases with unique findings. 
  • Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells. 
  • Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry. 
  • Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. 
  • Development and use of SIV-based Integrase defective lentiviral vector for immunization. 
  • Development of a model of melphalan-induced gastrointestinal toxicity in mice. 
  • Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation. 
  • Diacylglycerol kinase zeta positively controls the development of iNKT-17 cells. 
  • Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). 
  • Diagnosis and management of myeloproliferative disorders. 
  • Diagnosis of canine visceral leishmaniasis with a dot-enzyme-linked immunosorbent assay. 
  • Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature. 
  • Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium. 
  • Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms. 
  • Differences in chromatin proteins of resting and growing human lymphocytes. 
  • Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome. 
  • Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts. 
  • Distinctive characteristics of germinal center B cells. 
  • Donor specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population. 
  • Donor-specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population. 
  • Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. 
  • Dosimetry and microdosimetry of targeted radiotherapy. 
  • Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. 
  • Dyshematopoiesis in combined immune deficiency with congenital neutropenia. 
  • Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. 
  • EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs. 
  • Early hematopoiesis inhibition under chronic radiation exposure in humans. 
  • Early hematopoietic effects of chronic radiation exposure in humans. 
  • Editorial Commentary: Osteochondral Lesions of the Talus: All, Nothing, or Something in Between. 
  • Effect of basic fibroblast growth factor on angiogenesis and growth of isografted bone: quantitative in vitro-in vivo analysis in mice. 
  • Effect of intraocular gamma-interferon on immunoregulatory properties of iris and ciliary body cells. 
  • Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. 
  • Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. 
  • Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. 
  • Effects of nitrogen mustard and splenectomy on mouse bone marrow colony formation in vitro. 
  • Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow. 
  • Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. 
  • Emerging role of intensity-modulated radiation therapy in anorectal cancer. 
  • Endplate changes following discectomy: natural history and associations between imaging and clinical data. 
  • Energy dispersive x-ray detection of thorium dioxide. 
  • Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation. 
  • Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. 
  • Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. 
  • Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis. 
  • Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. 
  • Epidermal growth factor regulates hematopoietic regeneration after radiation injury. 
  • Erdheim-Chester disease collides with myelodysplastic neoplasm in bone marrow. 
  • Erythroleukemia: a study of 15 cases and literature review. 
  • Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia. 
  • Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia. 
  • Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer. 
  • Evaluation of four digestive methods for extracting diatoms. 
  • Evaluation of microRNA expression in patient bone marrow aspirate slides. 
  • Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia. 
  • Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. 
  • Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. 
  • Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. 
  • Exercise Increases Bone in SEIPIN Deficient Lipodystrophy, Despite Low Marrow Adiposity. 
  • Exercise and Diet: Uncovering Prospective Mediators of Skeletal Fragility in Bone and Marrow Adipose Tissue. 
  • Exposure to a youthful circulaton rejuvenates bone repair through modulation of β-catenin. 
  • Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells. 
  • Femoral head osteochondral lesions in painful hips of athletes: MR imaging findings. 
  • Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. 
  • Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib. 
  • Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia. 
  • Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis. 
  • General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family's perspective. 
  • Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease. 
  • Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. 
  • Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. 
  • Granulocytic sarcoma (chloroma) presenting as a dumbbell tumor. 
  • Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma. 
  • High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. 
  • Hodgkin's disease presenting as myelofibrosis. 
  • Human acute leukemia cells with membrane-bound immunoglobulin. 
  • Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts. 
  • Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. 
  • Hypertrophic chondrocytes serve as a reservoir for marrow-associated skeletal stem and progenitor cells, osteoblasts, and adipocytes during skeletal development. 
  • Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. 
  • Imaging Radiation-Induced Normal Tissue Injury to Quantify Regional Dose Response. 
  • Immune reconstitution syndrome in a patient with disseminated histoplasmosis and steroid taper: maintaining the perfect balance. 
  • Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. 
  • Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. 
  • Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates. 
  • Immunoreconstitution. 
  • Immunosenescence and germinal center reaction. 
  • Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. 
  • Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012. 
  • Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. 
  • In vitro and in vivo genotoxicity evaluation of hormonal drugs. I. Hydrocortisone. 
  • In vitro study of drug-induced granulocytopenia. 
  • Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria. 
  • Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice. 
  • Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice. 
  • Inhibitor of marrow thymidine incorporation from sera of patients with uremia. 
  • Intranuclear inclusions in Bence Jones lambda plasma cell myeloma. 
  • Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis. 
  • Intravital imaging of Ca(2+) signals in lymphocytes of Ca(2+) biosensor transgenic mice: indication of autoimmune diseases before the pathological onset. 
  • Iron homeostasis and erythropoiesis. 
  • Kinetics of immunoglobulin synthesis and secretion by resting and pokeweed mitogen-transformed human lymphocytes. 
  • Laboratory tests in the diagnosis of vitamin B12 (cobalamin) deficiency. 
  • Leukaemia hijacks a neural mechanism to invade the central nervous system. 
  • Leukemic ascites complicating acute myelomonoblastic leukemia. 
  • Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. 
  • Levels of p53 protein increase with maturation in human hematopoietic cells. 
  • Long-Term Clinical Outcomes of Severe Combined Immunodeficiency Patients Given Nonablative Marrow Transplants. 
  • Loss of atm radiosensitizes multiple p53 null tissues. 
  • Loss of β-catenin triggers oxidative stress and impairs hematopoietic regeneration. 
  • Low serum iron levels. 
  • Lymphadenopathy as the primary manifestation of malignant transformation in two patients with severe congenital neutropenia. 
  • Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. 
  • Lymphopenic immunologic deficiency in identical twins: lymphocyte allografting and graft-versus-host disease following treatment with albumin-gradient-separated paternal bone marrow cells. 
  • MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease. 
  • MR imaging of marrow changes adjacent to end plates in degenerative lumbar disk disease. 
  • Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. 
  • Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. 
  • Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival. 
  • Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. 
  • Microcytic anemia in mk/mk mice is not corrected by retroviral-mediated gene transfer of wild-type p45 NF-E2. 
  • Microdosimetric and Biological Effects of Photon Irradiation at Different Energies in Bone Marrow. 
  • Microdosimetry of astatine-211 using histological images: application to bone marrow. 
  • Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder. 
  • Mn(III) meso-tetrakis-(N-ethylpyridinium-2-yl) porphyrin mitigates total body irradiation-induced long-term bone marrow suppression. 
  • Mobile Health Technology for Pediatric Symptom Monitoring: A Feasibility Study. 
  • Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras. 
  • Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. 
  • Modulation of lymphocyte functions by group A streptococcal membrane. 
  • Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment. 
  • Morphologic, biochemical, and cytogenetic studies of bone marrow and circulating blood cells in painters exposed to ethylene glycol ethers. 
  • Multi-spin echo spatial encoding provides three-fold improvement of temperature precision during intermolecular zero quantum thermometry. 
  • Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. 
  • Murine Glucocorticoid Receptors Orchestrate B Cell Migration Selectively between Bone Marrow and Blood. 
  • Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. 
  • Music Intervention: Nonpharmacologic Method to Reduce Pain and Anxiety in Adult Patients Undergoing Bone Marrow Procedures. 
  • Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common. 
  • Myelodysplasia and deficiency of uridine diphosphate-galactose 4-epimerase. 
  • Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases. 
  • Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. 
  • Myelotoxicity from chemotherapy. 
  • NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. 
  • Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. 
  • Next Generation Bone Marrow Adiposity Researchers: Report From the 1^st BMAS Summer School 2021. 
  • Non-Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice. 
  • Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. 
  • Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern. 
  • Occult osteochondral lesions after anterior cruciate ligament rupture. Six-year magnetic resonance imaging follow-up study. 
  • Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. 
  • Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. 
  • Orbital recurrence of B-progenitor acute lymphoblastic leukemia in a child. 
  • Organ distribution of Corynebacterium parvum labeled with iodine-125. 
  • Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow. 
  • Outcomes of iliac crest bone marrow aspirate injection for the treatment of recalcitrant Achilles tendinopathy. 
  • P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. 
  • Paediatric leukaemia DNA methylation profiling using MBD enrichment and SOLiD sequencing on archival bone marrow smears. 
  • Pathologic changes associated with fatal Plasmodium falciparum infection in the Bolivian squirrel monkey (Saimiri sciureus boliviensis). 
  • Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response. 
  • Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis. 
  • Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma. 
  • Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks. 
  • Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid. 
  • Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. 
  • Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. 
  • Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. 
  • Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). 
  • Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. 
  • Practical murine hematopathology: a comparative review and implications for research. 
  • Predictive factors for response to anti-thymocyte globulin in acquired aplastic anemia. 
  • Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study. 
  • Prednisone-responsive aplastic anemia associated with T-lymphocyte proliferation. 
  • Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases. 
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. 
  • Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment. 
  • Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. 
  • Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. 
  • Prognotic significance of pretreatment proliferative activity in adult acute leukemia. 
  • Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient. 
  • Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials. 
  • Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. 
  • Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms. 
  • Pseudo-Gaucher cells in multiple myeloma. 
  • Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. 
  • Purging multidrug resistant cells from bone marrow. 
  • Purification and partial characterization of a human hematopoietic precursor population. 
  • Quantification of IGF-1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis. 
  • Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values. 
  • Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs. 
  • Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis. 
  • Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. 
  • Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. 
  • Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia. 
  • Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials. 
  • Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. 
  • Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome. 
  • Response of bone marrow to MC29 avian leukosis virus in vitro. 
  • Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery. 
  • Retinoblastoma metastatic to bone marrow. A case with florid spread. 
  • Risk of mortality in patients with cancer who experience febrile neutropenia. 
  • SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia. 
  • Second cessation of therapy in childhood lymphocytic leukemia. 
  • Sedimentation and volume analysis of human bone marrow. 
  • Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort - Methodologic aspects and definition of change. 
  • Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. 
  • Sequential lymphomas or clonally unrelated richter syndrome of chronic lymphocytic leukemia into mantle cell lymphoma. 
  • Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. 
  • Serial labeling index determination as a predictor of response in human solid tumors. 
  • Signet-ring cells in the bone marrow as an indication of cryptic metastasis of breast carcinoma: A case report. 
  • Single-Cell Mapping of Progressive Fetal-to-Adult Transition in Human Naive T Cells. 
  • Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations. 
  • Stem Cells in Cardiovascular Diseases: 30,000-Foot View. 
  • Stem cell factor expression in B cell malignancies is influenced by the niche. 
  • Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function. 
  • Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease. 
  • Sudden death due to undiagnosed T lymphoblastic leukemia/lymphoma in a 5-year-old boy. 
  • Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. 
  • Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer. 
  • Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia. 
  • TNF is required for the induction but not the maintenance of compression-induced BME signals in murine tail vertebrae: limitations of anti-TNF therapy for degenerative disc disease. 
  • Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. 
  • Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease. 
  • Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. 
  • Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity. 
  • Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. 
  • The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. 
  • The French-American-British (FAB) classification of leukemia. The Pediatric Oncology Group experience with lymphocytic leukemia. 
  • The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice. 
  • The effect of unilateral limb shielding on the haemopoietic response of the guinea-pig to gamma irradiation (150 r.). 
  • The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice. 
  • The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow. 
  • The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. 
  • The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors. 
  • The light microscopic demonstration of hydroperoxidase-positive Phi bodies and rods in leukocytes in acute myeloid leukemia. 
  • The morphology of the femur in developmental dysplasia of the hip. 
  • The pharmacology of methotrexate. 
  • The relationship between retinal vessel calibre and knee cartilage and BMLs. 
  • The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus. 
  • The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. 
  • The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy. 
  • The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission. 
  • The use of in vitro technics to study drug-induced pancytopenia. 
  • The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. 
  • Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice. 
  • Thrombocytopenia in allogeneic peripheral blood stem cell collections. 
  • Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. 
  • Topoisomerase II levels during granulocytic maturation in vitro and in vivo. 
  • Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma. 
  • Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. 
  • Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy. 
  • Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. 
  • Trypanosoma brucei gambiense: growth in vitro of bloodstream forms inhibited by dichlorodiammineplatinum (II) compounds and hypolipidemic drugs. 
  • Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog. 
  • Use of Hes1-GFP reporter mice to assess activity of the Hes1 promoter in bone cells under chronic inflammation. 
  • Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. 
  • Virus-infected avian cell lines established in vitro. 
  • Wolman Disease: A Mimic of Infant Leukemia. 
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. 
  • Xist RNA is a potent suppressor of hematologic cancer in mice. 
  • [Brain injury after induction chemotherapy in children with acute lymphoblastic leukemia]. 
  • [The mechanism of the antitumor effect of total/subtotal radiotherapy with non-tumoricidal doses of radiation]. 
  • β-Arrestin2 mediates progression of murine primary myelofibrosis. 
• 

  Keywords of People

  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Doan, Phuong Linh, Associate Professor of Medicine, Duke Cancer Institute
  • Erickson, Harold Paul, James B. Duke Distinguished Professor Emeritus, Cell Biology
  • Kelsoe, Garnett H., James B. Duke Distinguished Professor of Immunology, Integrative Immunobiology
  • Lagoo, Anand Shreeram, Professor of Pathology, Pathology
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Science & Society
  • Little, Sarah, Postdoctoral Associate, Evolutionary Anthropology
  • Stoecker, Maggie Marie, Assistant Professor of Pathology, Pathology
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology
  • Yildirim, Eda, Assistant Professor of Cell Biology, Cell Biology
  • Zhong, Xiaoping, Professor of Pediatrics, Integrative Immunobiology